Scarica l'app Stockscreener
17.82
0.37%
0.0781
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ROIV Giù?
Forum
Previsione
Precedente Chiudi:
$17.74
Aprire:
$17.65
Volume 24 ore:
5.81M
Relative Volume:
0.86
Capitalizzazione di mercato:
$12.18B
Reddito:
$125.68M
Utile/perdita netta:
$4.81B
Rapporto P/E:
3.1536
EPS:
5.65
Flusso di cassa netto:
$-781.21M
1 W Prestazione:
+8.57%
1M Prestazione:
+18.38%
6M Prestazione:
+77.34%
1 anno Prestazione:
+53.23%
Intervallo 1D:
$17.54
$17.93
Intervallo di 1 settimana:
$16.41
$18.06
Portata 52W:
$8.73
$18.06
Roivant Sciences Ltd Stock (ROIV) Company Profile
Nome
Roivant Sciences Ltd
Settore
Industria
Telefono
441-295-5950
Indirizzo
7TH FLOOR, 50 BROADWAY, LONDON
Confronta ROIV con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ROIV
Roivant Sciences Ltd
|
17.83 | 12.11B | 125.68M | 4.81B | -781.21M | 5.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.97 | 107.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
474.13 | 64.39B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
579.33 | 61.13B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
839.84 | 52.30B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
164.53 | 35.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Roivant Sciences Ltd Stock (ROIV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-02 | Iniziato | Citigroup | Buy |
| 2025-07-10 | Ripresa | Goldman | Buy |
| 2024-02-15 | Iniziato | Wolfe Research | Outperform |
| 2024-01-05 | Iniziato | Piper Sandler | Overweight |
| 2023-12-12 | Iniziato | Deutsche Bank | Buy |
| 2023-10-17 | Iniziato | Guggenheim | Buy |
| 2023-06-08 | Iniziato | BofA Securities | Neutral |
| 2022-10-27 | Iniziato | JP Morgan | Overweight |
| 2022-05-23 | Iniziato | SVB Leerink | Outperform |
| 2022-04-29 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-12-15 | Iniziato | Goldman | Buy |
| 2021-11-08 | Iniziato | H.C. Wainwright | Buy |
| 2021-10-28 | Iniziato | Citigroup | Buy |
| 2021-10-26 | Iniziato | Cowen | Outperform |
| 2021-10-26 | Iniziato | Jefferies | Buy |
| 2021-10-26 | Iniziato | Truist | Buy |
Mostra tutto
Roivant Sciences Ltd Borsa (ROIV) Ultime notizie
Wall Street Has a Mixed Opinion on Roivant Sciences Ltd (ROIV) - Insider Monkey
13 Best Growth Stocks Under $25 to Buy Right Now - Insider Monkey
Risk vs reward if holding onto Roivant Sciences Ltd.Wall Street Watch & Accurate Entry/Exit Alerts - newser.com
Chart based exit strategy for Roivant Sciences Ltd.Weekly Trading Summary & Weekly Stock Breakout Alerts - newser.com
Roivant Sciences Ltd. stock prediction for this weekMarket Performance Report & Weekly Stock Performance Updates - newser.com
Is Roivant Sciences Ltd. (87S) stock undervalued historicallyDip Buying & Long-Term Growth Stock Strategies - newser.com
Will Roivant Sciences Ltd. (87S) stock outperform benchmarksTrade Signal Summary & Daily Oversold Stock Bounce Ideas - newser.com
Is Roivant Sciences Ltd. (87S) stock a contrarian opportunityMarket Performance Report & Low Drawdown Investment Ideas - nchmf.gov.vn
Is a relief rally coming for Roivant Sciences Ltd. holders2025 AllTime Highs & Verified Momentum Stock Alerts - newser.com
Is Roivant Sciences Ltd. (87S) stock cheap by valuation metrics2025 Dividend Review & Real-Time Market Trend Scan - newser.com
Combining machine learning predictions for Roivant Sciences Ltd.July 2025 Weekly Recap & Technical Analysis for Trade Confirmation - newser.com
What sentiment indicators say about Roivant Sciences Ltd. stockJuly 2025 Retail & AI Forecasted Entry and Exit Points - newser.com
This Red-Hot Biopharma Stock Could Fizzle Out Soon - MSN
Can you recover from losses in Roivant Sciences Ltd.Earnings Overview Report & Precise Trade Entry Recommendations - newser.com
(ROIV) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Top chart patterns to watch in Roivant Sciences Ltd.Quarterly Market Summary & Verified Swing Trading Watchlist - newser.com
Roivant Sciences Ltd. (ROIV) Investor Outlook: Analyzing The 16% Potential Upside - DirectorsTalk Interviews
Using Ichimoku Cloud for Roivant Sciences Ltd. technicals2025 Trade Ideas & Weekly Setup with ROI Potential - newser.com
How sentiment analysis helps forecast Roivant Sciences Ltd.2025 Sector Review & Fast Moving Stock Watchlists - newser.com
Will Roivant Sciences Ltd. continue its uptrendJuly 2025 WrapUp & Daily Entry Point Trade Alerts - newser.com
Will Roivant Sciences Ltd. stock gain from government policiesDay Trade & Daily Technical Stock Forecast Reports - newser.com
Is Roivant Sciences Ltd. stock in correction or buying zoneMarket Activity Recap & AI Driven Price Predictions - nchmf.gov.vn
Roivant Sciences president Venker sells $14.5m in shares By Investing.com - Investing.com Nigeria
Roivant Sciences president Venker sells $14.5m in shares - Investing.com
Roivant Sciences Hits New 52-Week High of $17.12, Up 60.59% - Markets Mojo
Roivant Sciences stock hits all-time high at 16.8 USD By Investing.com - Investing.com South Africa
Roivant Sciences stock hits all-time high at 16.8 USD - Investing.com India
Can Roivant Sciences Ltd. stock deliver consistent earnings growth2025 Key Lessons & Weekly High Potential Stock Alerts - newser.com
Why retail investors pile into Roivant Sciences Ltd. stockQuarterly Growth Report & Stepwise Trade Signal Guides - newser.com
Roivant Sciences president Venker sells $2m in shares By Investing.com - Investing.com Australia
Roivant Sciences president Venker sells $2m in shares - Investing.com
Roivant Sciences Ltd Azioni (ROIV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Roivant Sciences Ltd Azioni (ROIV) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Venker Eric | President & Immunovant CEO |
Oct 16 '25 |
Option Exercise |
15.85 |
318,282 |
5,044,770 |
1,823,241 |
| Venker Eric | President & Immunovant CEO |
Oct 17 '25 |
Option Exercise |
15.85 |
118,418 |
1,876,925 |
1,623,377 |
| Venker Eric | President & Immunovant CEO |
Oct 15 '25 |
Sale |
16.93 |
414,683 |
7,020,583 |
1,504,959 |
| Venker Eric | President & Immunovant CEO |
Oct 16 '25 |
Sale |
17.05 |
318,282 |
5,426,708 |
1,504,959 |
| Venker Eric | President & Immunovant CEO |
Oct 17 '25 |
Sale |
17.06 |
118,418 |
2,020,211 |
1,504,959 |
2.01%
1.31%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):